Overview

A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2026-12-07

Target enrollment:

Participant gender:

Summary

The efficacy and safety of IAP0971 single drug or combined with BCG intravesical instillation in the treatment of high-risk non muscle invasive bladder cancer with BCG treatment failure.

Phase:

PHASE1

Details

Lead Sponsor:

SUNHO（China）BioPharmaceutical CO., Ltd.